• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男女血脂异常的最佳管理

Optimal management of dyslipidemia in women and men.

作者信息

Haymart M R, Allen J, Blumenthal R S

机构信息

School of Nursing and School of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

J Gend Specif Med. 1999 Nov-Dec;2(6):37-42.

PMID:11279870
Abstract

Relatively few studies have examined the clinical effectiveness of cholesterol-lowering drugs in women as compared with men. Most clinical trials do indicate that cholesterol lowering reduces clinical events equally effectively in both genders. However, high-density lipoprotein cholesterol and triglyceride levels may have more prognostic significance in women. The recent finding of a higher risk of death in younger women as compared with younger men who sustain a heart attack, combined with the high proportion of morbidity and mortality due to CHD in older women, emphasizes the need for a better understanding of heart disease in women. This review explores the similarities and differences between women and men regarding the management of dyslipidemia.

摘要

与男性相比,相对较少的研究考察了降胆固醇药物对女性的临床疗效。大多数临床试验确实表明,降低胆固醇对男女临床事件的减少效果相同。然而,高密度脂蛋白胆固醇和甘油三酯水平在女性中可能具有更大的预后意义。最近的研究发现,与发生心脏病发作的年轻男性相比,年轻女性的死亡风险更高,再加上老年女性中冠心病导致的高发病率和死亡率,凸显了更好地了解女性心脏病的必要性。这篇综述探讨了男女在血脂异常管理方面的异同。

相似文献

1
Optimal management of dyslipidemia in women and men.男女血脂异常的最佳管理
J Gend Specif Med. 1999 Nov-Dec;2(6):37-42.
2
Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.冠心病血脂异常管理中性别差异的回顾性研究:对来自马里兰州一家健康维护组织的患者数据的分析
Clin Ther. 2006 Apr;28(4):591-9. doi: 10.1016/j.clinthera.2006.04.012.
3
Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.以高密度脂蛋白胆固醇水平低为特征的人群中血脂异常的风险判定
Am Heart J. 2003 Dec;146(6):1052-9. doi: 10.1016/S0002-8703(03)00516-7.
4
A meta-analysis of randomized controlled studies on the effects of extended-release niacin in women.
Am J Cardiol. 2004 Jul 1;94(1):121-4. doi: 10.1016/j.amjcard.2004.03.042.
5
Women and coronary heart disease risk factors.女性与冠心病风险因素
J Cardiovasc Risk. 2002 Dec;9(6):315-22. doi: 10.1097/01.hjr.0000044514.34172.4d.
6
Status and management of blood lipids in Greek adults and their relation to socio-demographic, lifestyle and dietary factors: the ATTICA Study. Blood lipids distribution in Greece.希腊成年人血脂状况及管理及其与社会人口统计学、生活方式和饮食因素的关系:阿提卡研究。希腊的血脂分布情况。
Atherosclerosis. 2004 Apr;173(2):353-61. doi: 10.1016/j.atherosclerosis.2003.12.031.
7
Optimal management of cholesterol levels and the prevention of coronary heart disease in women.女性胆固醇水平的最佳管理与冠心病的预防
Am Fam Physician. 2002 Jan 15;65(2):217-26.
8
Pharmacologic treatment of type 2 diabetic dyslipidemia.2型糖尿病血脂异常的药物治疗。
Pharmacotherapy. 2004 Dec;24(12):1692-713. doi: 10.1592/phco.24.17.1692.52340.
9
Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).阿托伐他汀在患有严重血脂异常及心血管疾病或心血管疾病危险因素的女性中实现国家胆固醇教育计划低密度脂蛋白目标的疗效:女性阿托伐他汀胆固醇试验(WATCH)。
Am Heart J. 2001 Jun;141(6):949-56. doi: 10.1067/mhj.2001.115588.
10
Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day.腰围可预测“全国女性心脏日”筛查女性的心脏代谢风险及整体弗雷明汉风险。
J Womens Health (Larchmt). 2006 Jan-Feb;15(1):24-34. doi: 10.1089/jwh.2006.15.24.